Search results
Results from the WOW.Com Content Network
Apraclonidine , also known under the brand name Iopidine, is a sympathomimetic used in glaucoma therapy. It is an α 2 adrenergic receptor agonist and a weak α 1 adrenergic receptor agonist. [ citation needed ]
This article lists veterinary pharmaceutical drugs alphabetically by name. Many veterinary drugs have more than one name and, therefore, the same drug may be listed more than once. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name
Android phones, like this Nexus S running Replicant, allow installation of apps from the Play Store, F-Droid store or directly via APK files. This is a list of notable applications (apps) that run on the Android platform which meet guidelines for free software and open-source software.
Such apps are compiled in the Android-native APK file format which allows easy redistribution of apps to end-users. Most apps are distributed through Google's Play Store but many alternative software repositories, or app stores, exist. Alternative app stores use Android devices' "Unknown Sources" option to install APK files directly via the ...
The FDA enumerates veterinary drug approvals in the FDA Green Book. Drugs approved by the FDA for use in veterinary medicine are structurally similar to drugs approved for use in humans, owing to highly conserved physiology across species, and half of drugs approved for animals are separately approved for use in humans. [2]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
The mechanisms of sympathomimetic drugs can be direct-acting (direct interaction between drug and receptor), such as α-adrenergic agonists, β-adrenergic agonists, and dopaminergic agonists; or indirect-acting (interaction not between drug and receptor), such as MAOIs, COMT inhibitors, release stimulants, and reuptake inhibitors that increase the levels of endogenous catecholamines.
Tachyphylaxis (Greek ταχύς, tachys, "rapid", and φύλαξις, phylaxis, "protection") is a medical term describing an acute, sudden decrease in response to a drug after its administration (i.e., a rapid and short-term onset of drug tolerance). [1] It can occur after an initial dose or after a series of small doses.